Homocystinuria (Cystathionine β-Synthase Deficiency)
What is Homocystinuria (Cystathionine β-Synthase Deficiency)?
Homocystinuria is a rare genetic disorder that prevents your body from breaking down an amino acid called homocysteine. When the enzyme cystathionine β-synthase is missing or not working properly, homocysteine builds up to dangerous levels in your blood and urine. This buildup can damage blood vessels, bones, eyes, and the nervous system over time.
The condition is inherited in an autosomal recessive pattern. This means you need to receive one mutated gene from each parent to develop the disorder. People with one mutated gene are carriers but typically do not have symptoms. Homocysteine levels in people with this condition often rise above 100 micromoles per liter, far higher than the normal range of 5 to 15.
Early detection and treatment can prevent many of the serious complications. With proper management, many people with homocystinuria can lead healthy lives. The key is catching elevated homocysteine levels early and starting treatment before organ damage occurs.
Symptoms
- Dislocation of the lens in the eye, causing vision problems
- Severe nearsightedness or other vision changes
- Tall, thin build with long limbs and fingers
- Curved spine or chest deformities
- Weak, brittle bones that fracture easily
- Blood clots in veins and arteries
- Developmental delays or intellectual disability
- Seizures or movement problems
- Psychiatric symptoms like anxiety or behavioral changes
- Flushed cheeks or mottled skin appearance
Some infants with homocystinuria appear completely healthy at birth. Symptoms often develop gradually during the first years of life. Without newborn screening or early testing, the condition may not be diagnosed until serious complications occur.
Concerned about Homocystinuria (Cystathionine β-Synthase Deficiency)? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
Homocystinuria is caused by mutations in the CBS gene, which provides instructions for making the enzyme cystathionine β-synthase. This enzyme is essential for processing the amino acid methionine, which we get from protein in our diet. When the enzyme is missing or defective, homocysteine accumulates instead of being converted to cysteine. The excess homocysteine damages connective tissue, increases clotting risk, and affects brain development.
The condition is inherited, not caused by lifestyle factors. Both parents must carry a mutated gene for a child to develop homocystinuria. Each pregnancy between two carriers has a 25% chance of resulting in an affected child. Some ethnic groups have higher carrier rates, including certain Irish and Norwegian populations. Consanguinity, or reproduction between close relatives, also increases risk.
How it's diagnosed
Diagnosis begins with measuring homocysteine levels in the blood. People with homocystinuria typically have extremely elevated levels, often exceeding 100 micromoles per liter. Additional urine tests can detect high homocysteine in urine. Genetic testing confirms the diagnosis by identifying mutations in the CBS gene. Many states include homocystinuria in newborn screening panels, allowing detection before symptoms appear.
Rite Aid offers homocysteine testing as an add-on to our preventive health panel. Early detection through blood testing allows treatment to begin before complications develop. If homocysteine levels are significantly elevated, your doctor will order additional genetic testing and enzyme studies to confirm the diagnosis and guide treatment.
Treatment options
- High-dose vitamin B6 supplementation, which helps some people lower homocysteine levels
- Betaine supplements to help convert homocysteine to methionine
- Folic acid and vitamin B12 to support homocysteine metabolism
- Low-methionine diet with restricted protein intake
- Medical foods and special formulas designed for homocystinuria
- Regular monitoring of homocysteine levels through blood tests
- Anticoagulant medications to reduce blood clot risk in some cases
- Physical therapy and orthopedic care for bone and joint problems
- Vision care and monitoring for lens dislocation
- Working with a metabolic specialist and registered dietitian
Need testing for Homocystinuria (Cystathionine β-Synthase Deficiency)? Add it to your panel.
- Simple blood draw at your nearest lab
- Results in days, not weeks
- Share results with your doctor
Frequently asked questions
Homocystinuria is a rare inherited disorder where the body cannot properly break down the amino acid homocysteine. This causes dangerously high levels of homocysteine in the blood and urine. The condition results from a deficiency of the enzyme cystathionine β-synthase and can affect the eyes, bones, blood vessels, and nervous system.
Homocystinuria affects approximately 1 in 200,000 to 1 in 350,000 people worldwide. The condition is more common in certain populations, including people of Irish descent where rates can be as high as 1 in 65,000. Many states now include homocystinuria in newborn screening programs, which has improved early detection rates.
Many infants appear healthy at birth, with symptoms developing during early childhood. The first signs often include vision problems like severe nearsightedness or lens dislocation, usually appearing between ages 3 and 10. Developmental delays, a tall thin body type, and bone problems may also emerge early. Some children are diagnosed through newborn screening before any symptoms appear.
Yes, measuring homocysteine levels in the blood is the primary screening test for homocystinuria. People with the condition typically have extremely high levels, often above 100 micromoles per liter compared to normal levels of 5 to 15. Rite Aid offers homocysteine testing that can help detect elevated levels, though genetic testing is needed to confirm the diagnosis.
Homocystinuria is not curable because it is a genetic condition. However, it is highly treatable when detected early. Many people respond well to high-dose vitamin B6, which can significantly lower homocysteine levels. Those who do not respond to B6 can be managed with dietary changes, betaine supplements, and other medications to prevent complications.
Untreated homocystinuria can lead to serious complications including blood clots, stroke, and heart attacks even at young ages. Vision loss from lens dislocation and severe nearsightedness is common. Skeletal problems like osteoporosis and spine curvature worsen over time. Intellectual disability and developmental delays can occur if treatment is not started early in life.
People with homocystinuria need to limit high-protein foods that contain methionine. This includes meat, fish, eggs, dairy products, nuts, and legumes. A metabolic dietitian will create a specific meal plan that restricts methionine while ensuring adequate nutrition. Special medical foods and low-protein products are often used to replace regular high-protein foods.
About 50% of people with homocystinuria respond well to high-dose vitamin B6 supplementation. These individuals are called B6-responsive and can often achieve near-normal homocysteine levels with vitamins alone. The other 50% are B6-nonresponsive and require more intensive treatment including strict dietary restrictions and betaine supplements. A trial of B6 helps determine which group a person falls into.
Homocystinuria is present from birth because it is a genetic condition. However, some milder cases may not be diagnosed until adolescence or adulthood, especially before newborn screening became common. Adults with previously undiagnosed homocystinuria may present with blood clots, early heart disease, or bone problems before the underlying cause is identified.
People with homocystinuria typically need homocysteine levels checked every few months when treatment is first started. Once levels are stable, testing may be reduced to every 6 to 12 months. More frequent monitoring is needed during growth spurts, illness, or when treatment changes. Regular blood tests ensure that homocysteine stays in the target range to prevent complications.